Mutual funds demonstrated increased activity in July, actively participating in both anchor books of newly listed companies and initial public offerings (IPOs). Emcure Pharmaceuticals emerged as the most popular choice among mutual funds, with a significant portion of their investments allocated to this newly listed company. Data reveals that mutual funds purchased 6.59 million shares …